SFX by Ex Libris Inc.

Title:	Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel
Source:	Embo Journal [0261-4189] Saegusa, H yr:2001

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Campbell, James N N. "Mechanisms of Neuropathic Pain." Neuron 52.1 (2006): 77-92.
description	2.	Scott, David A. "Actions of intrathecal Ï-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat." European Journal of Pharmacology 451.3 (2002): 279-86.
description	3.	Bowersox, T. "Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain." The Journal of pharmacology and experimental therapeutics 279.3: 1243-1249.
description	4.	Kim, D. "Thalamic control of visceral nociception mediated by T-type Ca2+ channels." Science 302.5642 (2003): 117-9.
description	5.	Vasko, Michael R. "Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C." Pain 105.1-2 (2003): 133-141.
description	6.	Truini, A. "Pathophysiological mechanisms of neuropathic pain." Neurological sciences 27.2 (2006): 179-82.
description	7.	Woolf, Clifford J. "The neuropathic pain triad: neurons, immune cells and glia." Nature neuroscience 10.11 (2007): 1361-8.
description	8.	Scholz, J. "Can we conquer pain?" Nature neuroscience 5.Suppl. (2002): 1062-7.
description	9.	DeLeo, Joyce A A. "Basic science of pain." Journal of bone and joint surgery. American volume 88.2 (2006): 58-62.
description	10.	Wassilew, Sawko W W. "Zoster-associated neuralgias." Journal der Deutschen Dermatologischen Gesellschaft 4.10 (2006): 871-9.
description	11.	Schaible, H. "Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia." Pain 85.1-2 (2000): 9-18.
description	12.	Fink, K. "Inhibition of neuronal Ca2+influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices." British Journal of Pharmacology 130.4 (2000): 900-906.
description	13.	Seto, Y. "Influence of dosing times on cisplatin-induced peripheral neuropathy in rats." BMC cancer (2016): 756-756.
description	14.	McCleskey, Edwin W. "Calcium channels: cellular roles and molecular mechanisms." Current Opinion in Neurobiology 4.3 (1994): 304-312.
description	15.	Hughes, Y. "Gabapentin inhibits the substance P-facilitated K+-evoked release of [H-3]glutamate from rat caudal trigeminal nucleus slices." Pain 93.2 (2001): 191-196.
description	16.	Stevens, C W. "Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion." The Journal of pharmacology and experimental therapeutics 250.1 (1989): 1-8.
description	17.	Wilder-Smith, L G. "Surgical pain is followed not only by spinal sensitization but also by supraspinal antinociception." British journal of anaesthesia 76.6 (1996): 816-21.
description	18.	Tulunay, A. "Reversal of experimental neuropathic pain by T-type calcium channel blockers." Pain 105.1-2 (2003): 159-168.
description	19.	Yaksh, A B B. "Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats." Pain 60.1: 83-90.
description	20.	Altier, C. "Differential role of N-type calcium channel splice isoforms in pain." The journal of neuroscience 27.24 (2007): 6363-6373.